Fundraising Fox
Torigen Pharmaceuticals
Farmington, US · Delaware corporation · 7 known investors
Find your way into Torigen Pharmaceuticals
Sign up to see every warm intro you have to Torigen Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Torigen Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Torigen provides cancer diagnostics and personalized immunotherapy for veterinary patients, partnering with veterinary clinics to offer specialty pathology and autologous cancer vaccines made from a patient's own tumor tissue. Its approach targets tumor-specific antigens to treat cancer in pets.
Founders & leadership
Investors · 7
How we know: Chloe Capital's portfolio page · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Emerald Development Managers's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
__Twitter.png)
How we know: funding news · gaingels.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 4 of 5 rounds · 2019–2022
▶$4.6MraisedMay 2022 · 30 investors · PharmaceuticalsRule 506(b)
- Blake HawleyDirector
- Kevin CrowleyDirector
- John KallassyExecutive Officer
- Musan DuricDirector
- Ashley KalinauskasExecutive Officer, Director
- Elizabeth GalbutDirector
- Offering amount
- $10M
- Amount sold
- $4.6M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedDec 2021 · 16 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer, Director
- Kevin CrowleyDirector
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Blake HawleyDirector
- Elizabeth GalbutDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMar 2021 · 38 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer, Director
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Elizabeth GalbutDirector
- Kevin CrowleyDirector
- Blake HawleyDirector
- Offering amount
- $3.5M
- Amount sold
- $3.3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJan 2019 · 9 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer
- Mark SuckowExecutive Officer, Director
- Brad PoffExecutive Officer
- Terry DewExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Torigen Pharmaceuticals.
In the news
Frequently asked questions
- What does Torigen Pharmaceuticals do?
- Torigen provides cancer diagnostics and personalized immunotherapy for veterinary patients, partnering with veterinary clinics to offer specialty pathology and autologous cancer vaccines made from a patient's own tumor tissue. Its approach targets tumor-specific antigens to treat cancer in pets.
- Who founded Torigen Pharmaceuticals?
- Torigen Pharmaceuticals was founded by Ashley Kalinauskas.
- Who are Torigen Pharmaceuticals's investors?
- Torigen Pharmaceuticals's investors include Chloe Capital, Connecticut Innovations, Emerald Development Managers, Gaingels, Launchpad Venture Group, SoGal Ventures, The Fund.
- How much funding has Torigen Pharmaceuticals raised?
- Torigen Pharmaceuticals has disclosed $10.9M raised across 4 of its 5 known rounds.
- Where is Torigen Pharmaceuticals headquartered?
- Torigen Pharmaceuticals is headquartered in Farmington, US.